Document ID: chunk:federal_register_of_legislation:F2024L01036:clause:2_13
Version: federal_register_of_legislation:F2024L01036
Segment Type: clause
Provision Reference: sch 2 cl 13
Character Range: 7486–8167

13  Tests
 (1) Subject to subsection (2), for each item in the table in Schedule 2, a MDMA hydrochloride product must comply with the requirements specified in column 4 using the test method specified in column 3, in relation to the test specified in column 2.
 (2) This section does not apply to an extemporaneously compounded MDMA hydrochloride product where:
           (a) the MDMA hydrochloride used in the manufacture of that product was tested in accordance with the requirements specified in section 9 of this instrument; and
           (b) the testing was conducted at a site that is covered by a manufacturing licence granted by the Secretary under Part 3-3 of the Act.